Member Info for HarChris

Not much added there. We knew cash position as of April so cash burn is around £1.5m a month. Revenue looks ok to me.

After the £5m outflow to the DHSC ncyt vey much need that £12.2m vat reclaim although they'll get by just fine if they are tardy with returning it to us.

Lots appears to be happening in terms of r&d and product development but it still remains to be seen if it will culminate in significant revenue growth.

Another here to say thanks to ‘Muck’ who shares so much valuable research on ABDX, brilliant stuff.

And i’m another predicting there won’t be an opportunity to buy cheaper than the placing price on the open market.

Loudspeaker, when the poster goes on about the move in gold having had no effect on the share price here that’s exactly why holders think it’s so undervalued now.

Some (one) are trying to make out that there must be something wrong behind the scenes but there’s no evidence for it and as far as we know this next six months will blow all that have come before it out of the water. Plus there’s news expected on multiple other fronts.

The only issue is lack of liquidity but buyers will come as the news flow picks up through H2 and price will move quick.

Yeah that’s the below poster means.

Always annoying in the short term but ABDX is looking ever the exciting growth stock - I like how it was emphasised that this acquisition is being part paid by cash flows.

Assidall my posts have all been pretty balanced, I just hate the way rampers jump on the share for a few days after an update then disappear.

For the final time definitely a positive update today overall although lots of work for the new CEO ahead.

No Orange we don't know when they drew down the most recent $10m loan, some of that was likely in Q2 so cash burn probably higher - also they didn't reiterate the cash flow break even by H2'25 in this update.

Beevorma no fortunately not quite such a disaster for me here. I was out before and immediately after the shocking Q1 update for a ~40% loss then bought back in a few weeks ago (much smaller) as a punt - made back some of my losses today.

You’re missing the point - those numbers are what’s needed to reach cash flow positive. STX is miles off and will need to see much greater growth on the prescription side to get there without further funding. That looks unlikely although maybe the new CEO will do a lot better.

I hold so no benefit to my negativity.

One could argue that the market expects missed targets, gold price to fall, minimal mine life extension, funding for Douta to be prohibitively expensive leaving THX with $125m net cash when Segilola is all said and done.

If you think things will work out way better than that then is a great entry.

Rereading broker notes this morning.

30p target base on 2024 - 98k oz, $1144/oz aisc, POG $2084, 2025 - 101k oz, $1114/oz aisc, POG $2177.

If costs rise (not expecting that) still THX will be beating the numbers for Canaccord's 30p target. They also add 5p for each extra year of mine life at Segilola.

My target remains 35p

It needs to grow far faster than that - last year Hardman forecast $62.5m revs for 2024 and $120m for 2025.

Current cash will last the year now though and that is good news.

Not massive volume but far above average and nearly all occurring at the end of the trading day.

If the seller doesn't persist this morning then I suspect sp will finish modestly up today.

Yes I think so, the current cash figure probably includes more draw down from the debt facility too.

STX are miles off reaching a cash flow positive position as i've pointed out below, hence why Greg has gone, but on the plus side they do have cash in the bank so there's still the possibility that significant growth continues from here right through to profitability.

It's no doubt an improvement.

Aiming for something like 500k prescriptions per year at $220 Net Rx so miles off the trajectory needed to reach cash flow positive but still fairly happy with my recent buy down at these levels.

Whilst some bicker back and forth the rest of us will sit back patiently in what is one of the lowest risk small cap AIM shares out there.

Keep your eye on the price of gold - if it remains this high through the rest of 2024 we are almost certainly making very good returns from here.

All those watching this stock aren't going to be switching off til 6pm.

Be surprising if there's nothing before tomorrow's open.

'shot to bits' is a tad hyperbolic no? 40p to 82p and back down to 68p over the past month is a step in the right direction.

You mean 1 year and four weeks.

Biden was inaugurated in Jan 2021, Russia invaded Ukraine in Feb 2022.

LW what you're clearly missing is that in what is one of the toughest markets in decades for small caps and in a sector that has seen sentiment go from one extreme to the other it is a major accomplishment for a pre revenue graphite explorer like BRES to pull off placing after placing at the same level.

Bres has investor support in a way the majority of the same stage peers simply do not right now.

There's already new leadership, John Wood has gone.

Nobody thinks his leave of absence is temporary.

There's never anywhere close to a full turnout when it comes to any vote. 95m shares in issue and total votes cast will probably end up around 60m so 45m shares supporting delisting will do it.

Most will vote for what directors have unanimously recommended.